Company Details
|
|
Address
|
935 Main Street, Waltham, MA 02451
|
|
Telephone
|
(781) 899 7755
|
|
Fax
|
(781) 899 8482
|
Executives
|
|
Chairman
|
Richard Clothier (0.00% holding)
|
|
Finance Director
|
David Frank (0.00% holding)
|
|
Non-Exec Director
|
Eric Steiner**** (5.90% holding)
|
|
Non-Exec Director
|
Elliot Entis** (1.90% holding)
|
Main Shareholders
|
|
|
NANAF as Bay City Capital: 7.1%
Western Pharmaceuticals S.A. & Corporation Farmaceutica Recalcine: 7.1%
CSM Partners: 4.9%
Lou Barnett*: 4.6%
|
Advisers
|
|
Nominated Adviser
|
Nomura
|
|
Nominated Broker
|
Nomura
|
|
Solicitors
|
Jones Day
|
|
Auditors
|
Ernst & Young
|
|
Registrar
|
Capita Registrars
|
|
Commentary
|
|
Develops and markets biotechnology products to enhance the profitability of shrimp and fish farming operations
|
Company Data |
| Code |
ABTX |
| Sedol |
USU7569610 |
| Shares In Issue |
49.966 m |
| Indices
|
|
| Entry on AIM |
20/03/2006 |
| Interim Results |
Sep |
| Final Results |
May |
| Year End |
Dec |
| Accounts Due |
n/a |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
|
| |
|
|
